(IN BRIEF) TreeFrog Therapeutics has secured €30 million in financing from the European Investment Bank to advance its cell therapy program for Parkinson’s disease and support the development of its internal pipeline targeting diseases with high unmet needs. The funding, … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged 3D microtissues, bioreactors, C-Stem, cell therapy, dilutive financing, EIB, European Investment Bank, Healthcare Innovation, InvestEU, iPSCs, Microfluidics, Parkinson's disease, partnership, Regenerative medicine, stem cell biology, sustainability, TreeFrog Therapeutics, venture debt, €30 million financing
HORIZON-RIA PROJECT GRANTED FOR THE EARLY DETECTION OF SEPSIS AT THE POINT-OF-CARE DISRUPTIVE SOLUTION FOR SEPSIS DIAGNOSIS AT THE POINT OF CARE THAT WILL OFFER MULTIPLEXED (WITHIN A SINGLE TEST) (IN BRIEF)The AMBROSIA project has been granted under the call … Read the full press release
Posted in Czech Republic, Education, European Union, France, Greece, Healthcare, Ireland, Netherlands, News, Pharma & Biotech, Science, Spain, Switzerland, Technology, United Kingdom
Tagged AMBROSIA, Argotech, Aristotle University of Thessaloniki, Biopix DNA Technology P.C., Catalan Institute of Nanoscience and Nanotechnology, diagnostics, Dr. Alexandros Pantazis, HORIZON-RIA, intelligent sepsis diagnosis, Ligentec, Microfluidics, microLIQUID, nucleic acids, Optical Sensor, PoC, PoC sepsis diagnostic unit, Point of Care, Prof. Nikos Pleros, SEPSIS, SMART PHOTONICS BV, University of Bourgogne, University of Ioannina, University of Southampton, Vall d'Hebron Research Institute, X-Celeprint
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?